0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch united states psoriatic arthritis drug industry 2016 market research report.Your search for "" gave back 1533064 results.
Highlights The global Psoriatic Arthritis (PsA) Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Summary HeyReport estimates that the Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025,...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary The Musculoskeletal Disorders Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Summary The Tumor Necrosis Factor (TNF) Inhibitor Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Tumor Necrosis Factor (TNF) Inhibitor Drugs market size will grow from xxx Million USD in 2020 to xxxx Million...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Axial Spondyloarthritis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2018 Summary According...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary According to the...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Tyrosine Protein...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
GIR
January 2023
Price: USD 3,480.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
